LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback